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Cellular Transcription Factors Induced in Trigeminal Ganglia during
Dexamethasone-Induced Reactivation from Latency Stimulate Bovine
Herpesvirus 1 Productive Infection and Certain Viral Promoters
Aspen Workman,a,b James Eudy,c Lynette Smith,d Leticia Frizzo da Silva,a,f Devis Sinani,a,f Halie Bricker,e Emily Cook,a Alan Doster,b
and Clinton Jonesa,b,f
School of Biological Sciences, University of Nebraska, Lincoln, Lincoln, Nebraska, USAa; Nebraska Center for Virology, University of Nebraska, Lincoln, and Morrison Life
Science Center, Lincoln, Nebraska, USAb; Department of Genetics Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, USAc; Center for
Collaboration on Research, Design and Analysis, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USAd; Nebraska Wesleyan University,
Lincoln, Nebraska, USAe; and School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska, USAf
Bovine herpesvirus 1 (BHV-1), an alphaherpesvirinae subfamily member, establishes latency in sensory neurons. Elevated corti-
costeroid levels, due to stress, reproducibly triggers reactivation from latency in the field. A single intravenous injection of the
synthetic corticosteroid dexamethasone (DEX) to latently infected calves consistently induces reactivation from latency. Lytic
cycle viral gene expression is detected in sensory neurons within 6 h after DEX treatment of latently infected calves. These obser-
vations suggested that DEX stimulated expression of cellular genes leads to lytic cycle viral gene expression and productive infec-
tion. In this study, a commercially available assay—Bovine Gene Chip—was used to compare cellular gene expression in the tri-
geminal ganglia (TG) of calves latently infected with BHV-1 versus DEX-treated animals. Relative to TG prepared from latently
infected calves, 11 cellular genes were inducedmore than 10-fold 3 h after DEX treatment. Pentraxin three, a regulator of innate
immunity and neurodegeneration, was stimulated 35- to 63-fold after 3 or 6 h of DEX treatment. Two transcription factors, pro-
myelocytic leukemia zinc finger (PLZF) and Slug were inducedmore than 15-fold 3 h after DEX treatment. PLZF or Slug stimu-
lated productive infection 20- or 5-fold, respectively, and Slug stimulated the late glycoprotein C promoter more than 10-fold.
Additional DEX-induced transcription factors also stimulated productive infection and certain viral promoters. These studies
suggest that DEX-inducible cellular transcription factors and/or signaling pathways stimulate lytic cycle viral gene expression,
which subsequently leads to successful reactivation from latency in a small subset of latently infected neurons.
Bovine herpesvirus 1 (BHV-1) is an alphaherpesvirinae sub-family member that causes significant economical losses to
the cattle industry (86). The ability of BHV-1 to suppress the im-
mune system can result in life-threatening pneumonia due to sec-
ondary bacterial infections. Thismultifactorial disorder is referred
to as bovine respiratory disease complex (reviewed in references
35 and 39). Like different alphaherpesvirinae subfamilymembers,
the primary site for BHV-1 latency is sensory neurons within tri-
geminal ganglia (TG). Viral gene expression (73) and infectious
virus (29) are detected in TG from 1 to 6 days after acute infection.
Lytic cycle viral gene expression is subsequently extinguished in
sensory neurons, and latency is established. The BHV-1 genome is
stably maintained in sensory neurons, but infectious virus is not
detected by standard virus isolation procedures (reviewed in ref-
erences 33 and 34). The only viral gene abundantly expressed in
latently infected sensory neurons is the latency-related (LR) gene
(reviewed in reference 38). Stress, due to confinement, transport-
ing cattle, restricting food and water, weaning, or increased corti-
costeroid levels increases the incidence of reactivation from la-
tency (35, 39). The latency reactivation cycle of BHV-1 is crucial
for virus transmission and survival in nature (33, 34).
Administration of the synthetic corticosteroid dexamethasone
(DEX) to latently infected calves or rabbits consistently initiates
reactivation from latency (29, 33, 34, 37, 38, 68). A single intrave-
nous injection ofDEX also leads to lytic cycle viral transcription in
neurons within 6 h after treatment of latently infected calves (87,
89). DEX represses LR promoter activity (36) and reduces LR-
RNA levels, which reduces the number of TGneurons that express
LR-RNA at 18 to 21 h after treatment (68). Calves latently infected
with wild-type (wt) BHV-1 or LR mutant virus, which does not
reactivate from latency (29), frequently express bICP0 mRNA af-
ter DEX treatment, but only wt BHV-1 expresses late genes (94),
which correlates with virus shedding during reactivation from la-
tency (29). These findings are consistent with an earlier study that
concluded DEX induces viral gene expression in many latently
infected neurons, but only a subset of these neurons produce in-
fectious virus (68). DEX treatment of latently infected calves also
induces apoptosis of T cells that persist in TG after infection (87).
Persistence of T cells in TG of humans or mice latently infected
with HSV-1 also occurs (9, 25, 48, 77–79, 82), and persistent
CD8 T cells in TG produce factors that promote maintenance of
latency (41, 42, 46, 47, 66). Although DEXmay have many effects
that promote reactivation from latency, the ability ofDEX to stim-
ulate lytic cycle viral gene expression is predicted to be crucial for
successful reactivation from latency.
In the present study, cellular gene expression was examined in
TG during the early stages of DEX-induced reactivation from la-
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tency using a commercially available bovine array. Within 90 min
or 3 h after DEX treatment, 7 or 11 genes, respectively, were stim-
ulated at least 10-fold in the TG of calves latently infected with
BHV-1. The Pentraxin 3-like gene, which regulates innate im-
mune responses and neurodegeneration, was stimulated more
than any other gene by DEX (63-fold at 6 h after DEX treatment).
Two cellular transcription factors—zinc finger and BTB domain
containing 16, also referred to as promyelocytic leukemia zinc
finger (PLZF), and Snail homolog 2 (also known as Slug in mam-
mals)—were induced more than 15-fold at 3 h after DEX treat-
ment. Additional transcription factors induced by DEX were also
identified. Plasmids expressing these respective cellular transcrip-
tion factors activated productive infection and certain viral pro-
moters, suggesting that these cellular transcription factors pro-
mote lytic cycle viral gene expression during the early stages of
reactivation from latency.
MATERIALS AND METHODS
Cells and virus.Murine neuroblastoma (neuro-2A), rabbit skin (RS), and
bovine kidney (CRIB) cells were grown in Earle’s modified Eagle medium
supplemented with 10% fetal calf serum, penicillin (10 U/ml), and strep-
tomycin (100 g/ml).
A BHV-1 recombinant virus (gCblue) containing the lacZ gene in
place of the viral gC genewas obtained from S. Chowdhury (BatonRouge,
LA). The virus grows to similar titers as the wild-type parent virus and
expresses the -Gal gene as a true late gene.
Calf studies.BHV-1-free crossbred calves (200 kg)were used for the
present study. Calves were inoculated with 107 PFU of BHV-1 into each
nostril and eye for a total of 4 107 PFU/animal as described previously
(29, 30, 50, 61–63). Calves were housed under strict isolation and given
antibiotics before and after BHV-1 infection to prevent secondary bacte-
rial infection. At 60 days postinfection, calves were injected intravenously
(jugular vein) with 100 mg of DEX. Calves were then transported to the
Veterinary Diagnostic lab. Prior to euthanasia by electrocution, calves
were heavily sedated with xylazine. After decapitation, TG were collected,
and samples from each TG were formalin fixed and then paraffin embed-
ded. The remainder of both TG was minced into small pieces and placed
into a single 50-ml conical tube, and the tube was placed in a dry ice
ethanol bath. TG samples were then stored at80°C. After decapitation,
it took approximately 5 min to collect the TG, mince the TG, place the
pieces in a 50-ml conical tube, and then submerge the tube in a dry ice-
ethanol bath. One calf was decapitated at a time, to ensure that TG was
processed in a timely manner to reduce the possibility of degrading RNA.
Calves were decapitated in the same order in which they were injected
withDEX to ensure that the time points after DEX treatment were as close
as possible to the designated time point. Three calves/time point were
used for these studies. Experiments were performed in accordance with
the American Association of Laboratory Animal Care guidelines, and the
University of Nebraska IACUC committee.
RNApreparation formicroarray analysis and reverse transcription.
TG fromBHV-1-infected calves were collected at necropsy at 60 days after
infection (latency) and at 1.5, 3, 6, or 24 h after DEX treatment and then
stored at 80°C. TG were minced into small pieces, the tissue was solu-
bilized with a Polytron tissue homogenizer, and the total RNA was pre-
pared using TRIzol reagent (Life Technologies) as previously described
(95).
Microarray processing. Microarray studies were performed at the
University of Nebraska Medical Center (UNMC) Microarray Core Facil-
ity in Omaha, Nebraska. Briefly stated, 200 ng of total RNA was reverse
transcribed, processed using an Affymetrix 3= IVT Express kit, and hy-
bridized according to the manufacturer’s suggested protocols for the Bo-
vine Gene Chip assay (Affymetrix, Santa Clara, CA), which containsmore
than 23,000 genes. After overnight hybridization, arrays were stained and
scanned with the Affymetrix 450 fluidics station and a 3000 7G high-
resolution scanner. After quality control assessment was performed with
respect to background and other standardized parameters, as suggested by
Affymetrix, the .cel files were used for further analysis.
Microarray data analyses were conducted with BRBArrayTools devel-
oped by Richard Simon and Amy Peng. Robust multiarray average RMA
was used to do background correction, quantile normalization, and me-
dian polish summarization of probe-level data (31). A preliminary filter
was applied retaining genes where at least 20% of the arrays had at least a
1.5-fold change from the median value for that gene. To determine dif-
ferentially expressed genes over time, we compared control (0 h) andDEX
1.5-, 3-, 6-, and 24-h groups using a random variance F-test and then
selected genes with a false discovery rate of 10%. Fold changes were
calculated for each differentially expressed gene relative to the control
group. Heat maps were created to display differentially expressed genes
using Gene Cluster and TreeView (13, 16).
RT-PCR. To confirm microarray data, reverse transcription-PCR
(RT-PCR) was performed. One microgram of RNA was treated with
amplification-grade DNase I (Invitrogen). RT was performed using
SuperScript III reverse transcriptase (Invitrogen) according to the manu-
facturer’s directions. RNA was reverse transcribed using oligo(dT) prim-
ers (Invitrogen). Portions (100 ng) of the resulting cDNA were used as a
template for PCR using specific primers for the cellular gene of interest.
PCR was performed using GoTaq DNA polymerase (Promega) and initi-
ated at 95°C for 5 min. This was followed by 30 cycles of 95°C for 45 s,
annealing at the temperatures listed below for 45 s, and 72°C for 45 s. Final
extensionwas performed at 72°C for 10min. PCR products were analyzed
on a 1.3% agarose gel. The following primer sequences and PCR condi-
tions were used: GATA6, forward primer (5=-CACCAGTATCGCCCTT-
3=) and reverse primer (CCTGTGGGTTAGTCACACTA), at an anneal-
ing temperature of 48°C; SPDEF, forward primer (5=-CAAGAAGGGCA
TCATCCG-3=) and reverse primer (5=-CCCTCTTTCCCAGCTCTG-3=),
at an annealing temperature of 48°C; PLZF, forward primer (5=-TCTTT
GGCATATGGGCTCAGTC-3=) and reverse primer (5=-AGGCTGACTT
CTGTCTCCACA-3=), at an annealing temperature of 51°C; Slug, forward
primer (5=-GACCCCAGAATGGAACAGC-3=) and reverse primer (5=-C
AGGATTGCCTAACACACAGC-3=), at an annealing temperature of
51°C; KLF4, forward primer (5=-AAGACCAGAACCCCTTGAG-3=) and
reverse primer (5=-GACTTACCAAGCACCATCG-3=), at an annealing
temperature of 48°C; KLF6, forward primer (5=-GCCTTACAGATGCTC
ATGGG-3=) and reverse primer (5=-GTCTCTTCATGTGCAGGGC-3=),
at an annealing temperature of 51°C; Pentraxin, forward primer (5=-AA
GGAGAGAGTTGAGAT-3=) and reverse primer (5=-TTCTCCAGTCTC
CCTT-3=), at an annealing temperature of 46°C; and GAPDH, forward
primer (5=-CCATGGAGAAGGCTGGGG-3=) and reverse primer (5=-CA
AAGTTGTCATGGATGACC-3=), at an annealing temperature of 55°C.
Detection of viral DNA in the TG of calves. TG slices obtained from
the TG pieces collected from infected calves were suspended in cold TNE
buffer (50 mMTris [pH 7.5], 100 mMNaCl, 10 mM EDTA) plus sodium
dodecyl sulfate (SDS) 0.1% and then solubilized in a Polytron homoge-
nizer. Samples were then treated with RNase (40 g/ml) for 1 h at 37°C,
followed by proteinase K (250 g/ml) treatment for 3 h at 37°C and then
at room temperature in the dark overnight. Total DNAwas extractedwith
phenol-chloroform-isoamyl alcohol (25:24:1), followed by chloroform
only and precipitated by 100% ethanol at80°C. DNA was suspended in
TE buffer and used as a template for PCR with primers specific for the
BHV-1 glycoprotein B (gB) gene (forward, 5=-GTGGTGGCCTTTGACC
GCGAC-3=; reverse, 5=-GCTCCGGCGAGTAGCTGGTGT-3=). Ampli-
fied products were electrophoresed on a 1.5% agarose gel and stainedwith
ethidium bromide.
Quantifying-Gal-positive infected cells.The gCblue virus grows to
similar titers as wt BHV-1 and was grown in CRIB cells. Procedures for
preparing genomic DNA were described previously (95). RS cells grown
in six-well plates were cotransfected with 1g of the gCblue viral genome
and the designated amounts of plasmid expressing bICP0 or the DEX-
inducible cellular transcription factor of interest using Lipofectamine
Workman et al.
2460 jvi.asm.org Journal of Virology
  
htt 
D
ow
nloaded from
 
2000 (catalog no. 11668-019; Invitrogen). At 24 h after transfection, the
cells were fixed (2% formaldehyde and 0.2% glutaraldehyde in
phosphate-buffered saline [PBS]), stained (1% Bluo-Gal, 5 mM potas-
sium ferricyanide, 5 mM potassium ferricyanide, and 0.5 M MgCl2 in
PBS), and the number of -galactose-positive (-Gal) cells was deter-
mined as described previously (95). The number of -Gal cells in cul-
tures expressing the blank vector was set to 100%. To calculate percent
plaque formation, the number of blue cells in cultures transfectedwith the
cellular transcription factor were divided by the number of blue cells in
cultures transfected with the blank vector. This representation of the data
minimized the differences in cell density, Lipofectamine lot variation, and
transfection efficiency. The results are an average of at least three indepen-
dent experiments.
Small interfering RNA (siRNA) knockdown of cellular transcription
factors was accomplished by transfection of human osteosarcoma cells
(U2OS) with 100 nM specific siRNA or control RNA using Lipofectamine
2000 according to the manufacturer’s specifications. The Block-iT-
Fluorescent oligonucleotide was used as a control siRNA (catalog no.
44-2926; Invitrogen). It is a fluorescence-conjugated control containing a
scrambled sequence that does not reduce the levels of any known mam-
malian gene. At 24 h after transfection of the siRNA, cells were transfected
with 1 g of gCblue viral genome. At 24 h after the transfection of viral
genome, the cells were fixed, stained, and -Gal cells counted as de-
scribed above. The siRNAs were purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz) and were as follows: GATA6 (sc-37907), SPDEF (sc-
45845), PLZF (sc-37149), Slug (sc-38393), KLF4 (sc-35480), and KLF6
(sc-38021).
Western blot analysis. To evaluate the efficiency of siRNA knock-
down, U2OS cells were cotransfected with 0.5 g of a plasmid encoding a
DEX-inducible transcription factor and 100 nM the respective siRNA or
control siRNA as described above. At 36 h after transfection, whole-cell
lysatewas prepared. The cells werewashedwith phosphate-buffered saline
(PBS) and suspended in NP-40 lysis buffer (100 mMTris [pH 8.0], 1 mM
EDTA, 100 mMNaCl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride)
and one tablet of Complete protease inhibitor (Roche Molecular Bio-
chemicals) in 10 ml of buffer. The cell lysate was incubated on ice for 30
min, sonicated, and then clarified by centrifugation at 10,000  g at 4°C
for 15 min. The protein concentrations were quantified by the Bradford
assay. For SDS-PAGE, the proteins were mixed with an equal amount of
1 sample loading buffer (62.5 mM Tris-HCl [pH 6.8], 2% SDS, 50 mM
dithiothreitol, 0.1% bromophenol blue, 10% glycerol) and boiled for 5
min. Proteins were separated in a SDS–12% PAGE gel. After electropho-
resis, proteins were transferred onto a polyvinylidene difluoride mem-
brane (Immobilon-P; Millipore) and blocked for 4 h in 5% nonfat dry
milk with Tris-buffered saline–0.1% Tween 20 (TBS-T). Membranes
were then incubated with the designated primary antibody overnight at
4°C. The primary antibody was diluted 1:1,000 in the blocking solution.
An antibody directed against -actin (Santa Cruz Biotechnology, Santa
Cruz, CA) was used as a loading control. After 45 min of washing with
TBS-T, the blots were incubated with donkey anti-rabbit horseradish
peroxidase-conjugated immunoglobulin G (Amersham Biosciences),
which was diluted 1:2,000 in 5%nonfat milk in TBS-T. Blots were washed
45 min with TBS-T and exposed to Amersham ECL reagents, and then
autoradiography was performed. Primary antibodies were purchased
from Santa Cruz Biotechnology: GATA6 (sc-9055), SPDEF (sc-67022),
PLZF (sc-22839), KLF4 (sc-20691), and KLF6 (sc-7158). The secondary
donkey anti-rabbit antibody (NA9340V) was purchased fromGEHealth-
care. The KLF15 antibody (sc-271675) used for the present study is a
mouse monoclonal antibody purchased from Santa Cruz Biotechnology.
A secondary sheep anti-mouse antibody was purchased from GE Health-
care.
RT-PCR analysis of siRNAknockdownof Slug. Sincewewere unable
to detect Slug using the specific antibody, RT-PCR was performed to
confirm that the Slug siRNA reduced Slug mRNA levels. U2OS cells were
transfected with 100 nM Slug siRNA (sc-38393; Santa Cruz Biotechnol-
ogy) or a fluorescent control siRNA (catalog no. 44-2926; Invitrogen)
using Lipofectamine 2000 as described above. At 24 h after transfection,
total RNA was prepared from cells using TRIzol reagent (Life Technolo-
gies) as previously described (95). One microgram of RNA was treated
with amplification-grade DNase I (Invitrogen). RT was performed using
SuperScript III reverse transcriptase (Invitrogen) according to the manu-
facturer’s directions. RNA was reverse transcribed using oligo(dT) prim-
ers (Invitrogen). A 100-ng aliquot of the resulting cDNA was used as a
template for PCRusing specific primers for Slug (listed above). PCRprod-
ucts were analyzed on a 1.3% agarose gel.
Plasmids and promoter activity measured in transfected cells. The
construction and characteristics of the BHV-1 bICP0 E promoter-CAT
constructs (EP-172, EP-143, EP-133, EP-71, EP-50, and EP-42) used in
the present study were described previously (95). The numbers in the
plasmid name refer to the length of the bICP0 E promoter fragment
cloned into the promoterless vector, pCAT-basic (Promega). Truncations
to the promoter were made from the 5= terminus. IETu1-CAT contains
1.5 kb of upstream sequences cloned at the 5= terminus of pSV0CAT (a
promoter minus CAT expression vector). V. Misra, Saskatoon, Canada,
provided the IEtu1CAT plasmid (56). Two deletion constructs, 1024
and 1391 IEtu1, have 1,024- and 1,391-bp sequences removed from the
5= termini, respectively. The gC promoter constructs (gC-CAT, gC-PstI-
CAT, and gC-XhoI-CAT) were previously described (101). The empty
vector pcDNA3.1 was purchased from Invitrogen.
Neuro-2A cells grown in 60-mm dishes were cotransfected with the
designated plasmids as indicated in the respective figure legends using
TransIT Neural according to the manufacturer’s instructions. Measure-
ment of chloramphenicol acetyltransferase (CAT) activity in Neuro-2A
cells was performed as described previously (93, 95).
The GATA 6 expression vector was obtained from Paul Herring (In-
diana University School of Medicine). The KLF4 expression vector was
obtained from Jonathan Katz (University of Pennsylvania). The KLF6
expression vector was obtained from Bin Guo (North Dakota State Uni-
versity). The SPDEF expression vector was obtained fromOrigene (Rock-
ville, MD). The KLF15 expression vector was obtained from Deborah
Otteson (University of Houston). The PLZF expression vector was ob-
tained from Derek Sant’Angelo (Sloan-Kettering Cancer Center). The
Slug expression vector was obtained from Paul Wade (NIEHS, Research
Triangle Park, NC).
Immunohistochemistry. Immunohistochemistry was performed es-
sentially as previously described (54, 55, 87, 88) using an ABC kit (Vector
Laboratories). In brief, TG from calves used for the microarray studies
were fixed in neutral buffered formalin and then embedded in paraffin.
Thin sections (4 to 5 um) were cut and mounted onto slides. Tissue sec-
tions were incubated 20 min at 65°C, followed by two incubations of 10
min in xylene and rehydrated in graded alcohols. Tissue sections were
then incubated with 3% hydrogen peroxide in PBS (pH 7.4) for 20 min at
room temperature to block endogenous peroxidase. After three washes in
TBS (5min each) at room temperature, tissue sections were digested with
proteinase K (catalog nos. 53020[Dako]) for 20 min at 37°C. Tissue sec-
tions were then blocked with 5%normal serum diluted in TBS containing
0.25% bovine serum albumin for 45 min at room temperature in a hu-
midified chamber.
The designated rabbit polyclonal antibodies directed against cellular
transcription factors or the mouse monoclonal antibody directed against
KLF15 were used at a 1:1,000 dilution, incubated overnight in a humidi-
fied chamber at 4°C, and the next day washed in TBS (pH 7.6). Biotinyl-
ated goat anti-rabbit IgG (PK-6101; Vector Labs) or biotinylated donkey
anti-mouse IgG (PK-6102; Vector Labs) was then incubated with the sec-
tion for 30 min at room temperature in a humidified chamber. Next, the
avidin-biotinylated enzyme complex was added to slides for 30 min at
room temperature in a humidified chamber. After three washes in TBS,
slides were incubated with freshly prepared substrate (SK-4800; Vector
Labs), rinsed with distilled water, and counterstained with hematoxylin.
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Thin sections frommock-infected or latently infected calves were used as
a negative control.
RESULTS
Identification of DEX-regulated genes in TG.DEX reproducibly
induces reactivation from latency, as judged by virus shedding
fromocular or nasal cavities (1, 8, 24, 27, 37, 40, 68, 75, 87, 88). Six
hours afterDEX treatment viral transcripts are detected in a subset
of TG neurons by in situ hybridization using a probe that hybrid-
izes to ribonucleotide reductase, glycoproteinC, and ICP4 (68, 87,
89). The same probe does not readily detect viral gene expression
in calves latently infected with BHV-1 (60 days after infection).
Based on these observations, we predicted that viral gene expres-
sion is stimulated by DEX-inducible cellular factors expressed
prior to 6 h after DEX treatment. Consequently, we examined
cellular gene expression in TG at 90 min or 3, 6, or 24 h after DEX
treatment using a commercially available bovine GeneChip array.
These results were compared to those for cellular genes expressed
in TG during latency.
To identify cellular genes regulated by DEX that may promote
reactivation from latency, calves latently infected with BHV-1
were given a single intravenous injection of DEX (100 mg).
Seven genes were induced more than 10-fold within 90 min
after DEX treatment, and by 3 h after DEX treatment four of
these genes had levels that were less than that during latency
(Table 1). At 3 or 6 h after DEX treatment, eleven or eight
cellular genes were inducedmore than 10-fold. Only four genes
were identified that had a 10-fold induction relative to latency
at 24 h after DEX treatment.
Pentraxin-related gene three (PTX3) RNA levels were in-
creased more than 35- and 60-fold at three and 6 h after DEX
treatment, respectively (Table 1). PTX3 belongs to a family of
genes that are involved with innate immune response, neurode-
generation, and PTX3 reducesmouse cytomegalovirus replication
(5, 20). We predict that PTX3 may be detrimental to neuronal
survival and/or may interfere with reactivation from latency in
certain neurons. TheRNA levels of two transcription factors, Snail
homolog 2 (also referred to as Slug in mammals) and promyelo-
cytic leukemia zinc finger (PLZF) were increased more than 15-
TABLE 1 Genes induced more than 10 fold after DEX treatmenta
a Values are expressed as the fold induction at 1.5, 3, 6, and 24 h compared to TG of latently infected calves not infected with DEX.
Workman et al.
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fold at 3 h after DEX treatment. Slug and PLZF induction appear
to fit the time frame for stimulating viral gene expression and/or
productive infection during the early phases of reactivation from
latency.
Additional transcription factors were induced more than
3-fold by 6 h after treatment with DEX (Table 2). The SPDEF
(Sam-pointed domain containing Ets transcription factor) was
induced 6-fold at 3 and 6 h after DEX treatment. SPDEF encodes
a transcription factor belonging to the Ets (erythroblast transfor-
mation specific) family of transcription factors that regulate cell
lineage specification, proliferation, differentiation, angiogenesis,
and apoptosis (reviewed in references 23 and 74). The nuclear
factor of kappa light polypeptide gene enhancer in B cells inhibi-
tor, alpha (NFKB1A) encodes a 105-kDa protein that can undergo
processing by the 26S proteasome to produce a 50-kDa protein.
The 105-kDa protein is a Rel protein-specific transcriptional in-
hibitor, and the 50-kDa protein is a DNA binding subunit of the
NF-B protein complex (reviewed in reference 26).
Kruppel-like factor 15 (KLF15), which was induced 3.9-fold at
3 h after DEX treatment, belongs to a large family of transcription
factors that can function as either repressors or activators. PLZF
also belongs to the KLF family of transcription factors (reviewed
in references 4 and 23). Expression of KLF4 and KLF6 was stimu-
lated more than 10-fold in one calf, but not in the other calves.
KLF family members may be important factors during reactiva-
tion from latency because (i) they generally bind GC-rich motifs
resembling Sp1 binding sites or C-rich motifs (4), (ii) alphaher-
pesvirinae subfamily members are70% GC-rich, and (iii) most
viral promoters contain Sp1 binding sites. Zinc finger protein 36
homolog (ZFP36) is a protein encoded by the ZFP36 gene (14).
The ZFP36 protein binds to AU-rich elements (AREs) in the 3=-
untranslated regions (UTRs) of mRNAs of certain cytokines, in-
cluding tumor necrosis factor alpha, and promotes their degrada-
tion (10). The transcription factor GATA6 (99) was induced
6-fold in one calf at 3 and 6 h after DEX treatment, but not in the
other two calves at 3 or 6 h after DEX treatment.
The hairy and enhancer of split 6 (HES6) is a downstream
transcription factor in the Notch signaling pathway, which regu-
lates development, cell growth, and cell survival (7, 15). We re-
cently demonstrated that a protein encoded by the LR gene
(ORF2) interacts with Notch1 and Notch3 (93). Notch1 stimu-
lated productive infection and certain viral promoters, whereas
Notch3 did not stimulate productive infection and only activated
the BHV-1 glycoprotein C (gC) promoter. Notch3 (93) and
Notch4 (data not shown) RNA levels are also activated by DEX in
TG. As judged by the Ingenuity program, the Notch signaling
pathway was activated at 6 h after DEX treatment (data not
shown), adding support to our conclusion that the Notch signal-
ing pathway may regulate certain aspects of productive infection
and/or reactivation from latency.
The mRNAs of cellular genes that were reduced at least 4-fold
following DEX treatment are shown in Table 3. The only cellular
gene that was reduced more than 10-fold was the chemokine
CCL2 ligand 2. The transcription factor AP-2 alpha was also re-
duced more than 5-fold at 3 and 6 h after DEX treatment. In
summary, these studies demonstrated that DEX had a rapid effect
on cellular gene expression in TG of latently infected calves.
Analysis of DEX-inducible cellular genes by RT-PCR. To
confirm the changes in cellular gene expression identified by the
microarray studies, RT-PCR was performed. The genes examined
were PTX3, PLZF, and Slug, the three genes stimulated most by
DEX. Bovine GAPDH was used as a loading control. PCR prod-
ucts were separated by gel electrophoresis (Fig. 1A), and the rela-
tive amounts of the respective PCR products measured by densi-
tometry as described in Materials and Methods (Fig. 1B). The
graph represents the average density of three TG samples from
TABLE 2 Transcription factors induced more than 3-folda
a Values are expressed as the fold induction at 1.5, 3, 6, and 24 h compared to TG of latently infected calves not treated with DEX.
TABLE 3 Genes repressed at least 4-fold by DEXa
a Values are expressed as the fold induction at 1.5, 3, 6, and 24 h compared to TG of latently infected calves not treated with DEX.
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three calves at each time point. PTX3 RNA levels were readily
detected at 3 or 6 h after DEX treatment, but not prior to DEX
treatment. PLZF and SLUG RNA levels were highest at 3 h after
DEX treatment, but the levels decreased as a function of time after
DEX treatment. In summary, the RT-PCR results confirmed that
PTX3, PLZF, and Slug RNA levels were higher in TG of calves
latently infected with BHV-1 after DEX treatment.
PCR analysis was also performed to determine whether the
respective samples contained similar levels of viral DNA. This was
a concern because pieces of bovine TG were used for RNA prepa-
ration. To reduce the risk of choosing samples that did not contain
similar levels of latently infected neurons, the TG were minced
into small pieces at the time of necropsy. Thin slices were then
obtained from the individual frozen TG pieces, and this was used
to prepare total RNA or high-molecular-weight DNA. It was not
possible to examine LR-RNA expression for these studies because
it is well established that during DEX-induced reactivation from
latency LR-RNA levels are reduced dramatically (32, 68). Using gB
primers, we were able to readily detect viral DNA in all of the TG
of latently infected calves (Fig. 1C). As expected, there was some
variability in the levels of viral DNA detected in TG of the respec-
tive samples.
Analysis of DEX-induced cellular transcription factors by
IHC. As another confirmation of the results obtained by the mi-
croarray analysis, immunohistochemistry (IHC) was performed
to determine whether the cellular transcription factors were ex-
pressed in neurons, satellite cells, or infiltrating lymphocytes after
DEX treatment. A PLZF-specific antibody recognized a subset of
TG neurons at 1.5 h after DEX treatment. In general, we observed
areas where many neurons were recognized by PLZF at 1.5 h after
DEX (Fig. 2; arrows denote PLZF-positive neurons). Conversely,
other areas of TG sections contained few PLZF positive neurons.
At 3 or 6 h after DEX treatment, the number of PLZF-positive
neuronswas reduced. The PLZF antibody recognized few neurons
in TG sections from latently infected calves (Fig. 2) or at 24 h after
DEX treatment (data not shown). The commercially available
Slug antibody we tested did not specifically recognize a protein in
TG sections prepared from calves or when cells were transfected
with the Slug expression vector.
The SPDEF specific antibody weakly recognized a few TG neu-
rons in latently infected calves (Fig. 2) or uninfected calves (data
not shown). At 1.5, 3, or 6 h after DEX treatment, there weremore
neurons recognized by SPDEF relative to TG from latently in-
fected calves. At 3 h after DEX treatment, more neurons were
recognized by the SPDEF antibody compared to TG from 6 h
after DEX treatment. At 24 h after DEX treatment, the staining
was similar to that in TG of latently infected calves (data not
shown).
KLF4 and KLF6 antibodies yielded similar results. In general,
there were areas of TG from latently infected calves that were
recognized by the KLF4 or KLF6 antibodies (Fig. 2), and this was
similar to mock-infected calves (data not shown). At 1.5 h after
DEX treatment, there were areas in TG that contained high num-
bers of KLF4 or KLF6 positive neurons. After 1.5 h after DEX
FIG 1 RT-PCR confirmation of DEX-inducible cellular genes. (A) RT-PCR using specific primers was performed to analyze expression of cellular genes identified by
microarray analysis. Three latently infected calveswere treatedwithDEX for 1.5, 3, 6, or 24h. In addition, threemock (M)-infected calves aswell as three latently infected
calves (i.e., no DEX; L) were used as controls for baseline expression values. TG was collected at necropsy, and total RNA was isolated. RT-PCR was performed using
specific primers as described inMaterials andMethods. Products were separated by agarose gel electrophoresis and visualized using ethidium bromide. (B) Graphical
representationofRT-PCRresults.TheamountofPCRproductswasquantifiedusingabiomolecular imager (Bio-Rad), anddensityvalueswerenormalized toaGAPDH
control. Values represent the average of TG from three calves at each time point. (C) Total DNAwas prepared from the respective TG. Viral DNAwas amplified from
1g of DNAusing gB-specific primers. Genomic viral DNA extracted fromBHV-1-infected CRIB cells served as a template for the positive control PCR (). GAPDH
amplification was used as a loading control. The details of the PCR are described inMaterials andMethods.
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treatment, the number of neurons that were recognized by the
respective antibodies decreased. By 24 h after DEX treatment,
there were only a few neurons recognized by either KLF4 or KLF6
antibodies. The KLF15 specific antibody strongly reacted with
neurons in certain areas of TG sections at 1.5, 3, or 6 h after DEX
treatment (Fig. 2). Although KLF15-positive neurons were de-
tected in TG of latently infected neurons, the number of neurons
was fewer and the intensity of staining was low. At 24 h after DEX
FIG 2 Immunohistochemical (IHC) analysis of DEX-inducible transcription factors. Thin sections were cut from formalin fixed and paraffin embedded TG at
the designated times after calves latently infected with BHV-1 were treated with DEX. The sections designated as latency were at least 60 days after infection. IHC
was performed as described in Materials and Methods with antiserum directed against the designated DEX-inducible transcription factor. Arrows denote
neurons that were recognized by the respective antibody. Magnification,400.
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treatment, we observed a staining pattern similar to that observed
during latency (data not shown).
It was difficult to identify areas of TG neurons during latency
or after DEX treatment that were stained strongly by the GATA6
antibody. At 1.5, 3, or 6 h afterDEX treatment, a few neuronswere
weakly stained by the GATA6 antibody.With the exception of the
GATA6 antibody, antibodies directed against the DEX-inducible
transcription factors recognized more neurons at 1.5 h after DEX
treatment than the other time points examined. This may imply
that DEX induction of these specific transcription factors oc-
curred prior to 1.5 h of treatment.
DEX is an anti-inflammatory hormone, in part because it in-
activates NF-B signaling (reviewed in references 3 and 67). Con-
sequently, we examined expression of p65, a component of the
NF-B specific transcription factor that is necessary for activating
transcription, after DEX treatment. In contrast to the other cellu-
lar transcription factors examined, the number of neurons recog-
nized by the p65 specific antibody was high in TG neurons of
latently infected calves (Fig. 2). Although the p65 antibody did not
stain all neurons, it was relatively easy to identify clusters of neu-
rons recognized by the p65 antibody. In mock-infected TG, the
results were similar to latently infected calves (data not shown). In
contrast, the number of neurons recognized by the p65 antibody
was much lower after DEX treatment.
DEX-inducible transcription factors stimulate productive
infection. The data presented above indicated that DEX has a
rapid and direct effect on certain cellular transcription factors in
TGneurons of latently infected calves. However, these data do not
prove these factors promote reactivation from latency. Since we
predict that only a subset of latently infected neurons actually
produce infectious virus following DEX treatment, identifying
these neurons is difficult with the technology available today. To
determine whether these respective transcription factors play a
role in stimulating reactivation from latency, we tested whether
the respective DEX-inducible cellular transcription factors can
stimulate productive infection.
To test whether plasmids expressing a DEX-inducible cellular
transcription factor stimulated productive infection in cultured
cells, BHV-1 genomic DNA was cotransfected with a plasmid ex-
pressing one of the DEX-inducible cellular transcription factors,
and the efficiency of productive infection was measured. The
BHV-1 virus used for these studies is gCblue, which contains the
lacZ gene downstream of the gC promoter. This allows one to
measure productive infection by counting -Gal cells. The
gCblue virus grows to similar titers as wt BHV-1 in bovine cells,
and the number of -Gal cells directly correlates with plaque
formation (21, 22, 30, 55). As expected, bICP0 increased the levels
of-Gal cells by10-fold (Fig. 3A). PLZF increased the number
of -Gal cells 20-fold relative to the empty expression vector
(Fig. 3A). To achieve this level of activation, the amount of the
PLZF plasmid had to be higher than bICP0. KLF4 increased the
number of -Gal cells 9-fold. GATA6, KLF6, KLF15, SLUG, and
SPDEF increased the number of -Gal cells 4-fold relative to
an empty expression vector. The plasmid expressing p65 increased
the number of -Gal cells2-fold. Additional studies were per-
formed to test whether the cellular transcription factors had a
FIG 3 DEX-inducible transcription factors stimulate productive infection. (A) Rabbit skin (RS) cells were cotransfected with 62 ng of a plasmid encoding bICP0
or increasing concentrations of the respective plasmids (62 ng, 250 ng, 1 g, or 2 g) encoding DEX-inducible transcription factors, along with 1 g of gCblue
BHV-1 DNA, which contains the lacZ gene inserted into the gC locus of BHV-1. At 24 h after infection, cells were fixed, stained, and -Gal cells were counted.
The results are the average of three independent experiments. (B) As described for panel A, RS cells were cotransfectedwith increasing concentrations of plasmids
that express the designated DEX-inducible transcription factor (0.0662, 0.25, 1, or 2g of DNA). Tomaintain equivalent amounts of plasmid in the transfection
mixture, an empty expression plasmid (pcDNA3.1) was included. At 40 h after transfection, cell lysate was prepared and Western blotting was performed as
described in Materials and Methods. For each lane, 100 g of protein was loaded. The lane M denotes mock-transfected cells to allow determination of the
amount of the designated DEX-inducible transcription factor that was in normal cells. -Actin was used as a loading control.
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synergistic effect on productive infection. Although certain com-
binations had an additive effect, there was no evidence of syner-
gism (data not shown). When RS cells were transfected with
increasing amounts of a plasmid encoding a DEX-inducible tran-
scription factor, higher levels of the protein were detected (Fig.
3B). The commercially available Slug antibody we used did not
specifically recognize a protein. In summary, these studies indi-
cated that the DEX-inducible transcription factors stimulated
productive infection in RS cells.
Additional studies were performed to examine the effect of a
siRNA specific for certain DEX-inducible transcription factors on
BHV-1 productive infection. These studies were performed in a
human osteosarcoma (U2OS) cell line that is permissive for
BHV-1 infection (69) because commercially available siRNAs di-
rected against the bovine transcription factors are not available.
U2OS cells were transfected with 100 nM concentrations of the
respective siRNAs or a scrambled control siRNA 24 h prior to
transfection with the gCblue viral genome. At 24 h after transfec-
tion with the viral genome, the cells were fixed, stained, and
-Gal cells counted.With the exception of SPDEF, silencing of a
DEX-inducible cellular transcription factor reduced the number
of -Gal cells 2-fold (Fig. 4A). In RS cells, overexpression of
SPDEF enhanced productive infection, whereas silencing SPDEF
inU2OS cells increased productive infection. One explanation for
this difference may be that SPDEF has cell type-specific effects on
productive infection or in the highly transformed human tumor
cell line (U2OS) SPDEF was not important for productive infec-
tion. Western blot analysis confirmed that the siRNA specifically
reduced the respective transcription factor levels in U2OS cells
(Fig. 4B). Since the SLUG antibody did not recognize a specific
band, RT-PCR was performed to confirm that endogenous SLUG
mRNA levels were reduced (Fig. 4C).
DEX-induced cellular transcription factors activate certain
viral promoters. Additional studies were performed to test
whether the DEX-inducible cellular transcription factors transac-
tivated certain BHV-1 promoters. For these studies, we examined
the immediate-early transcription unit 1 promoter (IEtu1), bICP0
early (E) promoter, or the gC late (L) promoter. The IEtu1 pro-
moter activates expression of bICP0 and bICP4, the major tran-
scriptional regulatory proteins encoded by BHV-1 (90, 92). The
bICP0 E promoter also activates bICP0 expression, and previous
studies indicated that it is preferentially stimulated during reacti-
vation from latency (94). Neuro-2A cells were cotransfected with
the designated promoter construct and DEX-inducible gene,
and the CAT activity was measured at 48 h after transfection.
Neuro-2A cells were used for these studies because they are
neuron-like cells and are readily transfected. PLZF, which acti-
vated productive infection 21-fold, was unable to strongly trans-
activate any of the three viral promoters examined (Fig. 5). KLF4
activated the IEtu1 and bICP0 E promoter more than 50- and
100-fold, respectively, but not the gC promoter. KLF15 transacti-
vated the bICP0 E promoter 80-fold and the IEtu1 promoter
8-fold, but it had no effect on the gC promoter. KLF6 did not
have a dramatic effect on any of the three promoters examined.
Slug activated the IEtu1 promoter 5-fold and the gC promoter
13-fold but had no effect on the bICP0 E promoter. SPDEF acti-
FIG 4 siRNA directed against the DEX-inducible genes reduces the efficiency of productive infection. (A) Human osteosarcoma cells (U2OS) were transfected
with 100 nM siRNA targeting the designated cellular transcription factor or a control siRNA, which does not reduce the expression of any known mammalian
gene. After 24 h, the cells were transfected with gCblue viral genome and efficiency of productive infection wasmeasured as described inMaterials andMethods.
The results are the average of three independent experiments. (B) To confirm that the siRNAs reduced the levels of the expected proteins, U2OS cells were
cotransfected with 100 nM siRNA and 0.5 g of the designated plasmid expressing the DEX-inducible transcription factor. At 24 h after transfection, the cells
were collected and processed for Western blot analysis. -Actin was assayed as a loading control. Lane 1 was transfected with the control siRNA, and lane 2 was
transfected with the gene-specific siRNA. (C) The Slug antibody used for the present study did not recognize a specific protein in U2OS cells. Therefore, U2OS
cells were transfected with 100 nM Slug siRNA, control siRNA, or no siRNA, and RT-PCR was performed as described inMaterials andMethods. PCR products
were run on a 1.3% agarose gel and visualized with ethidium bromide.
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vated the gC promoter7-fold but activated the IEtu1 or bICP0 E
promoter5-fold. GATA6 stimulated the promoter minus con-
trol; thus, reliable data were not obtained for the three BHV-1
promoters. In summary, these studies suggested that DEX-
inducible transcription factors enhanced productive infection by
directly and/or indirectly regulating viral promoter activity.
Localization of KLF4 andKLF15 responsive sequences in the
IEtu1 promoter.The results presented in Fig. 5 demonstrated that
KLF4 andKLF15 activated the IETu1 and bICP0E promotermore
than 50- and 8-fold, respectively, in transient-transfection assays.
The KLF4 consensus binding sites are CACC or RCRCCYY (2,
12). KLF15 consensus binding sites are similar to KLF4 (59).
Three consensus CACC and five RCRCCYY sites were identified
in the IEtu1 promoter sequences (Fig. 6A). Five reverse CACC
motifs and nine reverse RCRCCYY motifs were detected in the
IEtu1 promoter.
To localize sequences in the IEtu1 promoter responsive to
KLF4 and KLF15, two deletion mutants were used (Fig. 6A). The
basal promoter activity of IEtu1cat1024 is 4-fold less than
IEtu1cat and IEtu1 cat1391 is 25-fold less than IEtu1cat (93).
Neuro-2A cells were cotransfected with the designated promoter
construct, along with KLF4 or KLF15, and CAT reporter activity
was measured at 48 h after transfection. KLF4 activated the full-
length IEtu1 25-fold and IEtu11024 and IEtu11391 50-fold
(Fig. 6B). AlthoughKLF15 transactivated the IEtu1 promoters less
FIG 5 DEX-inducible cellular transcription factors stimulate specific viral
promoters. Mouse neuroblastoma cells (Neuro-2A) were cotransfected
with 1 g of a CAT reporter plasmid with the IETu1 promoter
(IETu11024), the bICP0 E promoter (EP-638), or the gC L promoter and
1 g of pcDNA3.1 empty vector or 1 g of a plasmid expressing the desig-
nated DEX-inducible transcription factor. At 48 h after transfection, the
CAT reporter activity was measured. The numbers represent the fold in-
duction divided by the empty vector control. The results are the average of
three independent experiments.
FIG 6 Localization of KLF4 and KLF15 responsive sequences in the IETu1. (A) Positions of transcripts that encode bICP4 and bICP0. The immediate-early (IE)
transcription unit 1 (IEtu1) encodes bICP4 (IE/4.2) and bICP0 (IE/2.9) (91, 92). The IEtu1 promoter (denoted by the black rectangle) activates IE expression of
IE/4.2 and IE/2.9. E/2.6 is the early transcript that encodes bICP0, and an early promoter (denoted by the gray rectangle) activates expression of the early bICP0
transcript (E/2.6) (90). Exon 2 (e2) of bICP0 contains all of the protein coding sequences of bICP0. The dashed lines are intron sequences. KLF4 consensus
sequences were located in the IETu1 promoter using the free online program fuzznuc (http://emboss.open-bio.org/wiki/Appdocs). The KLF4 consensus binding
sites are CACC or RCRCCYY. The location of consensus KLF4 sequences in the IETu1 promoter and 5=UTR included in CAT constructs is shown. The reverse
(rev) sequences of CACCC and RCRCCYY are also shown. (B) Neuro-2A cells were cotransfected with the designated IETu1 promoter-CAT reporter plasmid (1
g) and 1 g of pcDNA3.1 empty vector or 1 g of KLF4 or KLF15. At 48 h after transfection, the CAT activity was measured. The numbers represent the fold
induction over the empty vector control. The results are the averages of three independent experiments.
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efficiently than KLF4, both transcription factors exhibited a sim-
ilar trend for transactivating the three IEtu1 promoter constructs.
IEtu11391 contains two CACC motifs, two RCRCCYY motifs,
one reverse CACC motif, and six reverse RCRCCYY motifs, sug-
gesting thesemotifs at the distal region of the IEtu1 promoterwere
not necessary for transactivation by KLF4 or KLF15.
Localization of KLF4 andKLF15 responsive sequences in the
bICP0 E promoter. To localize bICP0 E promoter sequences nec-
essary for KLF4- or KLF15-mediated transactivation, six deletion
mutants previously described (94, 95) were examined (Fig. 7A).
The basal promoter activity of EP-638, EP-398, EP-328, and EP-
172 does not vary more than 2-fold (94, 95). Relative to EP-638,
EP-133, and EP-71 have3-fold reduced basal promoter activity.
EP-638, EP-398, and EP-328 promoter activity were stimulated
100-fold by the KLF4 expression plasmid and 75-fold by the
KLF15 expression plasmid (Fig. 7B). EP-172 was activated 50-
fold by KLF4 and 40-fold by KLF15. In contrast, EP-133 and
EP-71 promoter constructs were activated 5-fold by KLF4 and
KLF15 (Fig. 7B). Two consensus KLF4/KLF15 binding sites
(CACCC) in the forward orientation plus one in the reverse ori-
entation were identified in EP-328. In addition, there was one
RCRCCYY motif in the forward orientation. The reduction of
KLF4 andKLF15 responsiveness between EP-328 and EP-172 cor-
related with the loss of one CACCC consensus in the forward
orientation plus a RCRCCYY motif. From EP-172 to EP-133,
there was a dramatic reduction in promoter responsiveness to
KLF4 and KLF15, which correlated with the loss of 1 CACCC
consensus in the reverse orientation. EP-133 retained oneCACCC
binding site: however, this single motif does not appear to be suf-
ficient for KLF4 or KLF15 responsiveness. EP-71 contained no
binding sites, which correlated with its inability to be stimulated
by KLF4 or KLF15.
DISCUSSION
In this study, the effect of DEX on cellular gene expression in TG
of calves latently infected with BHV-1was examined. As discussed
above, DEX consistently induces BHV-1 reactivation from cattle
(33, 34, 38, 39, 84). DEX is a synthetic corticosteroid that mimics
the effects of stress: consequently, DEX is a biologically relevant
stimulus to examine the steps that occur during BHV-1 reactiva-
tion from latency. Apart from the BHV-1 LR gene, other viral
transcripts are not abundantly transcribed during latency (re-
viewed in references 33, 34, 38, and 64). Since we have no evidence
that LR gene products stimulate viral transcription and LR-RNA
levels are reduced by DEX (68), cellular transcription factors in-
duced byDEXappear to be important for initiating lytic cycle viral
gene expression during the early phase of reactivation from la-
tency.
The cellular transcription factor, PLZF, was strongly induced
byDEXwithin 3 h afterDEX treatment and stimulated productive
infection by 20-fold, suggesting that it promotes reactivation from
latency. PLZF is also activated by glucocorticoid and progesterone
in human endometrial stromal cells andmyometrial smoothmus-
cle cells (17). Although several studies concluded that PLZF re-
presses transcription (19, 51, 53), phosphorylated PLZF activates
expression of interferon-stimulated genes (96). The inability of
PLZF to activate any of the BHV-1 promoters tested suggested
that PLZF (i) was not phosphorylated by the proper kinase in
transiently transfected cells, (ii) does not directly activate viral
transcription, (iii) activates a promoter that was not tested, (iv)
has neuron-specific transcriptional activity, and/or (v) “represses
a repressor” that is expressed during latency. PLZF is a member of
theKLF family of transcription factors (4). Several other KLF fam-
ilymembers (KLF4,KLF6, andKLF15)were also activated byDEX
in TG, suggesting that certain KLF transcription factors stimulate
lytic viral gene expression during reactivation from latency.
KLF4 and KLF15 transactivated both the bICP0 E promoter
and IEtu1 promoter: thus, it was not surprising to find KLF4
and/or KLF15 consensus binding sites in both promoters. KLF4
interacts with CACCC sequences (2, 12) and GAGGTCC or
GGGTGT motifs (57), which are necessary for Oct3/4 and KLF4
to cooperate with Sox2 to activate Lefty1 (left-right determination
factor 1) expression. KLF4 also interacts with the NF-B family
member p65 (RelA) to activate the iNOS (inducible nitric oxide
synthase) promoter (18), suggesting that interactions between
KLF4 and p65 are important for activating lytic cycle viral gene
expression. KLF4 is stimulated by heat stress (49) and, under cer-
tain circumstances, promotes apoptosis (100). Both heat stress
and apoptosis can increase the frequency of HSV-1 reactivation
from latency in vivo (72) or in cultured neurons (28). KLF4 also
stimulates the noncanonicalNotch signaling pathway (71). KLF15
encodes a protein that interacts with a CG/TCCCC motif, G-rich
motifs, or a CACCC site (59), and its expression is stimulated by
FIG 7 Localization of KLF4 and KLF15 responsive sequences in the bICP0 E
promoter. (A) Schematic of bICP0 E promoter constructs. KLF4 and KLF15
consensus sequences were located in the bICP0 E promoter using the free
online program fuzznuc (http://emboss.open-bio.org/wiki/Appdocs). These
consensus-binding sites (CACC or RCRCCYY) are shown in the bICP0 E
promoter. The reverse (rev) sequences of CACCC and RCRCCYY are also
shown. (B) Mouse neuroblastoma cells (neuro-2A) were cotransfected with
the designated bICP0 E promoter-CAT reporter plasmid (1 g) and 1 g of
pcDNA3.1 empty vector, 1 g of KLF4, or 1 g of KLF15. At 48 h after trans-
fection, the CAT activity was measured. The numbers represent the fold in-
duction over the empty vector control. The results are the averages of three
independent experiments.
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glucocorticoids (52, 80). KLF15 interacts with the Sp1 transcrip-
tion factor (97) and, like most KLF factors, activates certain pro-
moters while repressing others. These studies provide evidence
that KLF4 and KLF15 have the potential to stimulate lytic cycle
viral gene expression by several distinct mechanisms.
The finding that Slug and SPDEF transactivated the gC pro-
moter more efficiently than the bICP0 E or IEtu1 promoter sug-
gested that the normal cascade of viral gene expressionwas altered
during the early phases of latency. Slug was the only transcription
factor induced by 10-fold at 90 min after DEX treatment, im-
plying that transactivation of the gC promoter was an early event
during reactivation from latency. Several independent studies
concluded that the normal cascade of viral gene expression during
productive infection is different during reactivation from latency.
For example, the bICP0 E promoter, but not the bICP0 IE pro-
moter (IEtu1), is consistently stimulated during reactivation from
latency (94). HSV-1 E gene expression and DNA replication is
proposed to occur prior to IE gene expression during reactivation
from latency (43, 58, 65, 81). Finally, expression of a late HSV-1
gene (VP16), which activates expression of IE genes (70), was
proposed to stimulate reactivation from latency (83). Slug family
members, including Snail1 and Snail2, also reduce expression of at
least two proapoptotic proteins (Bid and p53) and consequently
inhibit apoptosis (44, 45). Perhaps increased levels of Slug pro-
mote successful reactivation from latency by enhancing the sur-
vival of latently infected neurons after DEX treatment.
None of the DEX-inducible transcription factors that we iden-
tified stimulated a BHV-1 VP16 promoter CAT construct by2-
fold (data not shown). However, when the same BHV-1 VP16
promoter CAT construct was transfected into bovine cells and
then infected with BHV-1, CAT activity was stimulated10-fold.
We had anticipated that the BHV-1 VP16 promoter would be
activated by DEX-inducible transcription factors because a recent
report concluded that expression of the HSV-1 VP16 promotes
the exit from latency (83). In general, our results suggested that the
BHV-1 VP16 promoter was not transactivated during the early
phases of reactivation from latency. It is also possible that cellular
transcription factors stimulated by DEX can transactivate the
BHV-1 VP16 promoter during the early stages of reactivation
from latency, but these are only expressed in a minor population
of latently infected neurons. If this scenario were true, these tran-
scription factors would be difficult to identify bymicroarray stud-
ies. It is also possible that BHV-1VP16, unlikeHSV-1VP16, is not
required for inducing reactivation from latency because bICP0 is
the trigger for BHV-1 reactivation from latency. Evidence sup-
porting a prominent role for bICP0 during BHV-1 reactivation
from latency comes from the finding that the bICP0 gene contains
two promoters: an early promoter and an immediate-early pro-
moter (IEtu1) (90, 91). The bICP0 early promoter, but not IEtu1,
is consistently stimulated by DEX-induced reactivation from la-
tency (94).
Our results provided evidence that several distinct steps occur
when the transition from maintenance of latency is disrupted by
DEX and reactivation from latency occurs (see Fig. 8 for a sche-
matic of these putative steps). During the maintenance of latency,
products encoded by the LR gene interfere with productive infec-
tion (6, 22, 32, 93), enhance neuronal survival (11, 50, 76), and
stabilize normal neuronal functions (60). Stressful stimuli, in this
case DEX, have several important effects on sensory neurons
within TG. The early events that occur in TG after DEX treatment
are operationally defined as the escape from latency. Important
events that occur during the escape from latency include: reduced
levels of LR gene products (68), apoptosis of infiltrating lympho-
cytes in TG (87), and induction of cellular gene expression. Lytic
cycle viral gene expression can be detected by in situ hybridization
within 6 h afterDEX treatment (87). That study also indicated that
only a small subset of neurons in TG expressed lytic cycle viral
genes, which agrees with an independent study by Rock et al. (68).
Activation of any viral gene during the escape from latency would
seem to favor extensive viral transcription. Many latently infected
neurons that escape latency are likely to reestablish or return to
latency (68) and thus would not produce infectious virus.
Increased expression of BHV-1 regulatory proteins—bICP0,
bICP4, or perhaps VP16—during the escape from latency may
lead to the normal cascade of viral gene expression in certain la-
tently infected neurons. Consequently, all viral proteins would be
expressed, and infectious virus would be produced. Interestingly,
the LRmutant virus, which does not reactivate from latency, con-
sistently expresses bICP0 transcripts in TG after DEX treatment
(94), suggesting that merely activating bICP0 expression is not
sufficient for reactivation from latency. Conversely, gC or VP16
transcripts (both late genes) were not detected when calves la-
tently infected with the LR mutant virus were treated with DEX.
There are several subtypes of murine sensory neurons in TG (98),
suggesting that certain subtypes of latently infected neurons pos-
sess the necessary factors to support production of infectious vi-
rus. None of the transcription factors identified in the present
study were induced when murine TG are explanted to induce
reactivation from latency (85), suggesting that stimulus-specific
events mediate reactivation from latency or explant-induced re-
activation from latency does not reflect the events that occur dur-
ing DEX-induced BHV-1 reactivation from latency in vivo.
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